Caryn E. Good

2.0k total citations · 1 hit paper
40 papers, 1.4k citations indexed

About

Caryn E. Good is a scholar working on Epidemiology, Pharmacology and Molecular Medicine. According to data from OpenAlex, Caryn E. Good has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 14 papers in Pharmacology and 13 papers in Molecular Medicine. Recurrent topics in Caryn E. Good's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (13 papers) and Pneumonia and Respiratory Infections (10 papers). Caryn E. Good is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (13 papers) and Pneumonia and Respiratory Infections (10 papers). Caryn E. Good collaborates with scholars based in United States, South Africa and United Kingdom. Caryn E. Good's co-authors include Michael R. Jacobs, Saralee Bajaksouzian, Anne Windau, Hillard M. Lazarus, Roslyn Yomtovían, Robert A. Bonomo, Robert W. Maitta, Hong Hong, Wenbin Xiao and Andrea M. Hujer and has published in prestigious journals such as Blood, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Caryn E. Good

36 papers receiving 1.4k citations

Hit Papers

Parabacteroides distasonis : intriguing aerotolerant gut ... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Parabacteroides distasonis : intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health
    2021 200 citations Jessica C. Ezeji, Hailey L. Erkkila et al. Gut Microbes profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caryn E. Good United States 18 508 322 284 255 249 40 1.4k
Elizabeth Palavecino United States 22 472 0.9× 110 0.3× 243 0.9× 210 0.8× 64 0.3× 89 1.4k
Viola Mae Young United States 28 603 1.2× 461 1.4× 83 0.3× 332 1.3× 363 1.5× 64 2.4k
Wendell H. Hall United States 24 541 1.1× 192 0.6× 40 0.1× 200 0.8× 354 1.4× 85 1.7k
Salim Mwarumba Kenya 16 363 0.7× 155 0.5× 28 0.1× 50 0.2× 18 0.1× 27 1.3k
Αndreas Mentis Greece 32 592 1.2× 184 0.6× 45 0.2× 542 2.1× 76 0.3× 109 3.2k
Denise Dekker Germany 20 187 0.4× 297 0.9× 7 0.0× 143 0.6× 19 0.1× 60 1.2k
P M Hawkey United Kingdom 13 133 0.3× 155 0.5× 30 0.1× 116 0.5× 45 0.2× 20 710
José Antonio Lepe Spain 20 522 1.0× 285 0.9× 27 0.1× 213 0.8× 141 0.6× 133 1.4k
Belén Gutiérrez‐Gutiérrez Spain 20 469 0.9× 1.1k 3.4× 41 0.1× 266 1.0× 437 1.8× 49 1.7k
Keiichi Mikasa Japan 20 420 0.8× 137 0.4× 24 0.1× 252 1.0× 99 0.4× 111 1.2k

Countries citing papers authored by Caryn E. Good

Since Specialization
Citations

This map shows the geographic impact of Caryn E. Good's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caryn E. Good with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caryn E. Good more than expected).

Fields of papers citing papers by Caryn E. Good

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caryn E. Good. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caryn E. Good. The network helps show where Caryn E. Good may publish in the future.

Co-authorship network of co-authors of Caryn E. Good

This figure shows the co-authorship network connecting the top 25 collaborators of Caryn E. Good. A scholar is included among the top collaborators of Caryn E. Good based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caryn E. Good. Caryn E. Good is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dutta, Sanjucta, Michael R. Jacobs, Caryn E. Good, et al.. (2025). Multicenter evaluation of the eQUANT system for use with disk diffusion AST of gram-negative bacteria directly from positive blood cultures. Journal of Clinical Microbiology. 63(6). e0160624–e0160624.
2.
West, Gail, Claudio Fiocchi, Fabio Cominelli, et al.. (2024). Genomes of Bacteroides ovatus , B. cellulosilyticus , B. uniformis , Phocaeicola vulgatus , and P. dorei isolated from gut cavernous fistulous tract micropathologies in Crohn's disease. Microbiology Resource Announcements. 13(4). e0115223–e0115223. 2 indexed citations
3.
Jacobs, Michael R., Caryn E. Good, Ayman M. Abdelhamed, et al.. (2024). ARGONAUT-IV: susceptibility of carbapenemase-producing Klebsiella pneumoniae to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibuten. Antimicrobial Agents and Chemotherapy. 68(12). e0112724–e0112724.
4.
Jacobs, Michael R., Ayman M. Abdelhamed, Caryn E. Good, et al.. (2024). ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime. Antimicrobial Agents and Chemotherapy. 68(9). e0075124–e0075124. 6 indexed citations
5.
Abdelhamed, Ayman M., Eszter Deák, Nitin K. Rajan, et al.. (2024). Pilot study evaluation of the eQUANT™ system for accelerated antimicrobial susceptibility testing of gram-negative organisms directly from positive blood cultures. Diagnostic Microbiology and Infectious Disease. 111(3). 116665–116665. 2 indexed citations
6.
Jacobs, Michael R., Caryn E. Good, Ayman M. Abdelhamed, & Robert A. Bonomo. (2022). Accuracy of Direct Antimicrobial Susceptibility Testing of Gram-Negative Bacteria from Positive Blood Cultures Using MicroScan System and Value of Using Expert Rules for β-Lactam Agents. Antimicrobial Agents and Chemotherapy. 66(3). e0214821–e0214821. 6 indexed citations
7.
Simner, Patricia J., Kimberlee A. Musser, Kara Mitchell, et al.. (2022). Multicenter Evaluation of the Acuitas AMR Gene Panel for Detection of an Extended Panel of Antimicrobial Resistance Genes among Bacterial Isolates. Journal of Clinical Microbiology. 60(3). e0209821–e0209821. 6 indexed citations
8.
Ezeji, Jessica C., Hailey L. Erkkila, Daniel E. Cohen, et al.. (2021). Parabacteroides distasonis : intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health. Gut Microbes. 13(1). 1922241–1922241. 200 indexed citations breakdown →
9.
Yang, Falong, Anand Kumar, Karen W. Davenport, et al.. (2019). Complete Genome Sequence of a Parabacteroides distasonis Strain (CavFT hAR46) Isolated from a Gut Wall-Cavitating Microlesion in a Patient with Severe Crohn’s Disease. Microbiology Resource Announcements. 8(36). 21 indexed citations
10.
Barnes, Melissa D., Caryn E. Good, Saralee Bajaksouzian, et al.. (2018). 698. Nacubactam Inhibits Class A β-lactamases. Open Forum Infectious Diseases. 5(suppl_1). S251–S252.
11.
Wallis, Robert S., Caryn E. Good, Mary Ann O’Riordan, et al.. (2018). Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial. PLoS ONE. 13(5). e0196756–e0196756. 6 indexed citations
12.
Jacobs, Michael R., Caryn E. Good, Ayman M. Abdelhamed, et al.. (2018). 1348. In vitro Activity of Plazomicin, a Next-Generation Aminoglycoside, Against Carbapenemase-Producing Klebsiella pneumoniae. Open Forum Infectious Diseases. 5(suppl_1). S412–S413. 2 indexed citations
13.
Harausz, Elizabeth, Keith Chervenak, Caryn E. Good, et al.. (2016). Activity of nitazoxanide and tizoxanide against Mycobacterium tuberculosis in vitro and in whole blood culture. Tuberculosis. 98. 92–96. 16 indexed citations
14.
Jacobs, Michael R., Saralee Bajaksouzian, Caryn E. Good, et al.. (2010). Novel bis-indole agents active against multidrug-resistant Acinetobacter baumannii. Diagnostic Microbiology and Infectious Disease. 69(1). 114–116. 13 indexed citations
15.
Jacobs, Michael R., Caryn E. Good, Saralee Bajaksouzian, & Anne Windau. (2008). Emergence ofStreptococcus pneumoniaeSerotypes 19A, 6C, and 22F and Serogroup 15 in Cleveland, Ohio, in Relation to Introduction of the Protein‐Conjugated Pneumococcal Vaccine. Clinical Infectious Diseases. 47(11). 1388–1395. 112 indexed citations
16.
Jacobs, Michael R., Caryn E. Good, Hillard M. Lazarus, & Roslyn Yomtovían. (2008). Relationship between Bacterial Load, Species Virulence, and Transfusion Reaction with Transfusion of Bacterially Contaminated Platelets. Clinical Infectious Diseases. 46(8). 1214–1220. 129 indexed citations
17.
18.
Pankuch, Glenn A., Gengrong Lin, Dianne B. Hoellman, et al.. (2006). Activity of Retapamulin against Streptococcus pyogenes and Staphylococcus aureus Evaluated by Agar Dilution, Microdilution, E-Test, and Disk Diffusion Methodologies. Antimicrobial Agents and Chemotherapy. 50(5). 1727–1730. 23 indexed citations
19.
Koeth, Laura, et al.. (2004). Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin. International Journal of Antimicrobial Agents. 24(2). 144–149. 8 indexed citations
20.
Koeth, Laura, Michael R. Jacobs, Caryn E. Good, et al.. (2004). Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000. International Journal of Infectious Diseases. 8(6). 362–373. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Palavecino Breakdown of academic impact, for papers by Viola Mae Young Breakdown of academic impact, for papers by Wendell H. Hall Breakdown of academic impact, for papers by Salim Mwarumba Breakdown of academic impact, for papers by Αndreas Mentis Breakdown of academic impact, for papers by Denise Dekker Breakdown of academic impact, for papers by P M Hawkey Breakdown of academic impact, for papers by José Antonio Lepe Breakdown of academic impact, for papers by Belén Gutiérrez‐Gutiérrez Breakdown of academic impact, for papers by Keiichi Mikasa
Rankless by CCL
2026